Xilio Therapeutics, Inc. (XLO) Revenue 2024–2025
Xilio Therapeutics, Inc. (XLO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$43.8MFY2025 · since FY2024: $6.3M → $43.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $43.8M | +589.9% |
| FY2024 | $6.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice